Biocon share price gained 2.61 per cent at Rs 398 a piece on the BSE in Thursday’s intraday trade. This came after the ...

The stock has gained 9.66% in the last month, 7.99% over the past six months, and an impressive 37.98% in the last year.

Biocon had a 54.45 percent stake in Syngene International as of September 30. The funds raised will go a long way towards helping the company repay the debt it had taken on for the acquisition of ...

Raising overseas debt has become prohibitively expensive due to the depreciating rupee, he explained, adding, "several Indian ...

Biocon Pharma, a subsidiary of Biocon, got China’s approval for Tacrolimus capsules (0.5mg, 1mg, 5mg). The immunosuppressant helps prevent organ rejection in transplant patients and strengthens ...

India's Biocon has partnered with US-based Mylan to sell Indian-made biogenerics globally. Bangalore-based Biocon sees the collaboration with Mylan, the world's third-largest generics producer ...

The funds raised will go a long way towards helping the company repay the debt it had taken on for the acquisition of Viatris Inc's biosimilars portfolio for over $3 billion. Biocon-Serum deal ...

The deal is valued at Rs 366 crore. The acquisition will be partially funded through debt financing. Biocon Limited retains eight position amongst Top 10 Employers in global biotech, pharma ...